Full Text View
Tabular View
No Study Results Posted
Related Studies
Timing of Planned Caesarean Section and Morbidity of the Newborn
This study is currently recruiting participants.
Verified by Aarhus University Hospital, April 2009
First Received: February 2, 2009   Last Updated: April 9, 2009   History of Changes
Sponsored by: Aarhus University Hospital
Information provided by: Aarhus University Hospital
ClinicalTrials.gov Identifier: NCT00835003
  Purpose

The caesarean section rate is rising globally. About 10% of the newborns are submitted to a neonatal department after planned caesarean section, primarily with respiratory disorders. More children are submitted if caesarean is performed earlier in pregnancy.

Study hypothesis: More newborns are admitted after planned caesarean at 38 weeks and 3 days of gestation than after 39 weeks and 3 days of gestation.

Aim of study: To compare elective caesarean section performed at 38 weeks and 3 days of gestation with 39 weeks and 3 days of gestation. According to this timing to determine the proportion of newborns admitted within 48 hours after birth.


Condition Intervention
Respiratory Disorders
Intensive Care, Neonatal
Procedure: Elective caesarean section

MedlinePlus related topics: Cesarean Section Surgery
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title: Timing of Elective Caesarean Section and Neonatal Morbidity - a Randomised Multicentre Study

Further study details as provided by Aarhus University Hospital:

Primary Outcome Measures:
  • Neonatal admission after elective caesarean section [ Time Frame: 48 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Neonatal diagnoses [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Duration of neonatal treatment with ventilator, CPAP, oxygen and/or antibiotics [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Maternal haemorrhage in ml or organ laceration during caesarean section. [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Maternal fever, wound infection, need of wound operative revision and antibiotics, duration of admission [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Maternal satisfaction with timing of elective caesarean section [ Time Frame: 2 months ] [ Designated as safety issue: No ]
  • Post partum depression [ Time Frame: 2 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 1010
Study Start Date: March 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
Elective caesarean section at 38 weeks and 3 days of gestation
Procedure: Elective caesarean section
Procedure performed at 38 weeks and 3 days of gestation (+/- 2 days)
2: Active Comparator
Elective caesarean section at 39 weeks and 3 days of gestation
Procedure: Elective caesarean section
Procedure performed at 39 weeks and 3 days of gestation (+/- 2 days)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elective caesarean section
  • Gestational age determined at 12 weeks ultrasound scan
  • Singleton pregnancy

Exclusion Criteria:

  • < 18 years of age (at time of randomization)
  • In need of an interpreter to communicate in danish
  • Diabetes, both gestational and before pregnancy
  • A mother with an estimated high risk of caesarean section before 39+5 weeks
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00835003

Contacts
Contact: Julie Glavind, MD +45 51955559 julie.glavind@ki.au.dk
Contact: Niels Uldbjerg, MD,Professor +45 89496315 uldbjerg@ki.au.dk

Locations
Denmark
Department of Obstetrics and Gynecology, Aarhus University Hospital Skejby Recruiting
Aarhus N, Denmark, 8200
Contact: Julie Glavind, MD, PhDstudent     0045 51955559     julie.glavind@ki.au.dk    
Regional Hospital of Randers Not yet recruiting
Randers, Denmark, 8930
Hospital of Kolding Recruiting
Kolding, Denmark, 6000
Aarhus University Hospital, Aalborg Hospital Not yet recruiting
Aalborg, Denmark, 9000
Regional Hospital of Viborg Not yet recruiting
Viborg, Denmark, 8800
Regional Hospital of Herning Not yet recruiting
Herning, Denmark, 7400
Sponsors and Collaborators
Aarhus University Hospital
Investigators
Principal Investigator: Julie Glavind, MD Department of Gynecology and Obstetrics, Aarhus University Hospital Skejby
Study Chair: Niels Uldbjerg, MD,Professor Department og Gynecology and Obstetrics, Aarhus University Hospital Skejby
Study Chair: Tine B Henriksen, MD, PhD Neonatal Department, Aarhus University Hospital Skejby
Study Chair: Sara F Kindberg, PhD, midwife Perinatal Research Unit, Aarhus University Hospital Skejby
  More Information

No publications provided

Responsible Party: Department of Gynecology and Obstetrics, Aarhus University Hospital Skejby ( MD Julie Glavind )
Study ID Numbers: AAUH091077
Study First Received: February 2, 2009
Last Updated: April 9, 2009
ClinicalTrials.gov Identifier: NCT00835003     History of Changes
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics;   Denmark: Danish Dataprotection Agency

Keywords provided by Aarhus University Hospital:
Neonatal admission
Elective Caesarean Section
Timing
Choice behavior
Intraoperative complications
Postoperative complications

Study placed in the following topic categories:
Respiratory Tract Diseases
Postoperative Complications
Respiration Disorders
Intraoperative Complications

Additional relevant MeSH terms:
Respiratory Tract Diseases
Respiration Disorders

ClinicalTrials.gov processed this record on May 07, 2009